Eli Lilly Retained Earnings (Accumulated Deficit) 2012-2026 | LLY

Eli Lilly retained earnings (accumulated deficit) for the quarter ending March 31, 2026 were $24.470B, a 80.66% increase year-over-year.

  • Eli Lilly retained earnings (accumulated deficit) for 2025 were $24.47B, a 80.66% increase from 2024.
  • Eli Lilly retained earnings (accumulated deficit) for 2024 were $13.545B, a 31.35% increase from 2023.
  • Eli Lilly retained earnings (accumulated deficit) for 2023 were $10.312B, a 2.69% increase from 2022.

Eli Lilly Retained Earnings (Accumulated Deficit) 2012-2026 | LLY

  • Eli Lilly retained earnings (accumulated deficit) for 2025 were $24.47B, a 80.66% increase from 2024.
  • Eli Lilly retained earnings (accumulated deficit) for 2024 were $13.545B, a 31.35% increase from 2023.
  • Eli Lilly retained earnings (accumulated deficit) for 2023 were $10.312B, a 2.69% increase from 2022.